DIA 2018
June 24-28, 2018 | Boston Convention & Exhibition Center (BCEC) | Boston, MA
The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe. Designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need to do your job every day, your attendance will accelerate your growth and your organization’s performance in the development ecosystem. Sessions will include distinguished speakers and expert panelists from regulatory, industry, patient advocacy, and academia. Engage with global decision makers and influencers in the biotechnology hub of 2018 that you would not otherwise have access to. Advance health care product development globally and grow your career while doing so.
Join Avoca for the Following Sessions:
| .
. .
. .
. . . . .
|
…….. | .
TUESDAY, JUNE 26 | 8:00am – 9:00am Oversight in the Era of E6 (R2)Component Type: Session Level: Intermediate This session will outline the characteristics that define common outsourcing models and expose their corresponding risk/benefit ratio with regard to sponsor and CRO oversight. Case studies of proven solutions within each model will be presented and linked to recommendations to achieve enhanced oversight in the era of E6 (R2). Learning Objectives: Discuss the risk/benefit ratio with regard to sponsor and CRO oversight in common outsourcing models; Identify methods to implement improved and more efficient approaches to clinical trial oversight.
Chair: Melissa Bomben, MS, Vice President, Strategic Resourcing, Syneos Health
Panelist: Crissy MacDonald, PhD, Executive Director, Client Delivery, The Avoca Group |
| .
. . . . . .
|
…….. | .
TUESDAY, JUNE 26 | 10:30am – 11:30am Executives Respond to the State of the Industry Report on Risk Based Approaches in Clinical Trials: Opportunity or Threat?Component Type: Forum Level: Intermediate Part didactic presentation, part lively debate and discussion among an executive panel, dive deep into the state of risk in clinical trials and explore our data on risk assessment and risk-based approaches to clinical trial oversight and execution. Learning Objectives: Identify the most recent information regarding the state of the industry for familiarity, use, impact and satisfaction with risk assessment and risk-based approaches in clinical research; Develop new perspectives on how to shape their individual and organizational perspectives and positioning with respect to changing regulatory requirements and evolving risk landscape.
Chair: Dennis Salotti, MBA, MS, Chief Operating Officer, The Avoca Group
Panelists: Neil McCullough, Executive Vice President, Clinical Quality and Compliance, ICON Clinical Research |
To schedule a meeting with an Avoca representative at this event, contact us.